Oncogene Function Inhibitors of Microbial Origin
Kazuo Umezawa
Publisher Summary
This chapter discusses the oncogene function inhibitors of microbial origin. Streptomyces and other microorganisms produce antibiotics, anticancer agents, and enzyme inhibitors as secondary metabolites. Therefore, microorganisms are a treasury of organic compounds that have various structures and biological activities. Isolation of the specific bioactive products in culture broths depends on the testing method. As oncogene theory has been extensively developed in the field of carcinogenesis research, oncogene function inhibitors have been screened as a new group of microbial secondary metabolites. The EGF-receptor-associated tyrosine kinase was reported ...
Get Discovery of Novel Natural Products with Therapeutic Potential now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
